Skip to content

International Journal of Gynecological Cancer

Just another bmjjournals-chicken.bmj.com Managed WordPress Site Sites site

Myeloid neoplasms post PARP inhibitors for ovarian cancer

Post navigation

Previous post

Case-mix adjustment to compare hospital performances regarding complications after cytoreductive surgery for ovarian cancer: a nationwide population-based study

Next post

Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions

Search

Recent Posts

Robots

Recent Comments

No comments to show.

Archives

September 2022

Categories

Uncategorized

International Journal of Gynecological Cancer

Proudly powered by WordPress.